v3.25.4
Restructuring Plans (Tables)
12 Months Ended
Dec. 31, 2025
Restructuring charges  
Summary of cash activity in the restructuring reserve
The following table summarizes the cash activity in the restructuring reserve for 2025, 2024 and 2023:
(in millions)
Accrued balance as of December 31, 2022$176 
Charges
107 
Payments and other adjustments(87)
Accrued balance as of December 31, 2023196 
Charges
168 
Payments and other adjustments(128)
Accrued balance as of December 31, 2024236 
Charges
166 
Payments and other adjustments(88)
Accrued balance as of December 31, 2025$314 
Allergan integration plan  
Restructuring charges  
Summary of charges associated with integration plan
The following table summarizes the charges associated with the Allergan acquisition integration plan:
year ended December 31 (in millions)2023
Cost of products sold$89 
Research and development
Selling, general and administrative192 
Total charges $288